Skip to main content

Research Repository

Advanced Search

Epitranscriptomic mechanisms of androgen signalling and prostate cancer

Patke, Rodhan; Harris, Anna E.; Woodcock, Corinne L.; Thompson, Rachel; Santos, Rute; Kumari, Amber; Allegrucci, Cinzia; Archer, Nathan; Gudas, Lorraine J.; Robinson, Brian D.; Persson, Jenny L.; Fray, Rupert; Jeyapalan, Jennie; Rutland, Catrin S.; Rakha, Emad; Madhusudan, Srinivasan; Emes, Richard D.; Muyangwa-Semenova, Musalwa; Alsaleem, Mansour; de Brot, Simone; Green, William; Ratan, Hari; Mongan, Nigel P.; Lothion-Roy, Jennifer

Epitranscriptomic mechanisms of androgen signalling and prostate cancer Thumbnail


Authors

Rodhan Patke

Rachel Thompson

Rute Santos

Amber Kumari

Lorraine J. Gudas

Brian D. Robinson

Jenny L. Persson

RUPERT FRAY RUPERT.FRAY@NOTTINGHAM.AC.UK
Professor of Epitranscriptomics

CATRIN RUTLAND CATRIN.RUTLAND@NOTTINGHAM.AC.UK
Professor of Molecular Medicine

EMAD RAKHA Emad.Rakha@nottingham.ac.uk
Professor of Breast Cancer Pathology

Richard D. Emes

Musalwa Muyangwa-Semenova

Mansour Alsaleem

Simone de Brot

William Green

Hari Ratan

NIGEL MONGAN nigel.mongan@nottingham.ac.uk
Associate Pro-Vice Chancellorglobal Engagement



Abstract

Prostate cancer (PCa) is the second most common cancer diagnosed in men. While radical prostatectomy and radiotherapy are often successful in treating localised disease, post-treatment recurrence is common. As the androgen receptor (AR) and androgen hormones play an essential role in prostate carcinogenesis and progression, androgen deprivation therapy (ADT) is often used to deprive PCa cells of the pro-proliferative effect of androgens. ADTs act by either blocking androgen biosynthesis (e.g. abiraterone) or blocking AR function (e.g. bicalutamide, enzalutamide, apalutamide, darolutamide). ADT is often effective in initially suppressing PCa growth and progression, yet emergence of castrate-resistant PCa and progression to neuroendocrine-like PCa following ADT are major clinical challenges. For this reason, there is an urgent need to identify novel approaches to modulate androgen signalling to impede PCa progression whilst also preventing or delaying therapy resistance. The mechanistic convergence of androgen and epitranscriptomic signalling offers a potential novel approach to treat PCa. The epitranscriptome involves covalent modifications of mRNA, notably, in the context of this review, the N(6)-methyladenosine (m6A) modification. m6A is involved in the regulation of mRNA splicing, stability, and translation, and has recently been shown to play a role in PCa and androgen signalling. The m6A modification is dynamically regulated by the METTL3-containing methyltransferase complex, and the FTO and ALKBH5 RNA demethylases. Given the need for novel approaches to treat PCa, there is significant interest in new therapies that target m6A that modulate AR expression and androgen signalling. This review critically summarises the potential benefit of such epitranscriptomic therapies for PCa patients.

Citation

Patke, R., Harris, A. E., Woodcock, C. L., Thompson, R., Santos, R., Kumari, A., Allegrucci, C., Archer, N., Gudas, L. J., Robinson, B. D., Persson, J. L., Fray, R., Jeyapalan, J., Rutland, C. S., Rakha, E., Madhusudan, S., Emes, R. D., Muyangwa-Semenova, M., Alsaleem, M., de Brot, S., …Lothion-Roy, J. (2024). Epitranscriptomic mechanisms of androgen signalling and prostate cancer. Neoplasia, 56, Article 101032. https://doi.org/10.1016/j.neo.2024.101032

Journal Article Type Article
Acceptance Date Jul 15, 2024
Online Publication Date Jul 20, 2024
Publication Date 2024-10
Deposit Date Aug 29, 2024
Publicly Available Date Sep 4, 2024
Journal Neoplasia
Print ISSN 1522-8002
Electronic ISSN 1476-5586
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 56
Article Number 101032
DOI https://doi.org/10.1016/j.neo.2024.101032
Public URL https://nottingham-repository.worktribe.com/output/37604077
Publisher URL https://www.sciencedirect.com/science/article/pii/S1476558624000745?via%3Dihub

Files





You might also like



Downloadable Citations